The Challenge AROA Biosurgery was at a crossroads. The New Zealand-based company was confident its soft-tissue regeneration product, EndoformTM Natural, was superior to existing collagen dressings for treating diabetic foot ulcers (DFUs). But how best to prove it? The potential for the product was enormous. Research indicates that up to one-third of the half billion people with diabetes worldwide will develop a DFU over the course of their lifetime.

Join for free to read